FR2777782B1 - Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires - Google Patents

Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires

Info

Publication number
FR2777782B1
FR2777782B1 FR9805425A FR9805425A FR2777782B1 FR 2777782 B1 FR2777782 B1 FR 2777782B1 FR 9805425 A FR9805425 A FR 9805425A FR 9805425 A FR9805425 A FR 9805425A FR 2777782 B1 FR2777782 B1 FR 2777782B1
Authority
FR
France
Prior art keywords
solution
diagnosis
ala
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9805425A
Other languages
English (en)
French (fr)
Other versions
FR2777782A1 (fr
Inventor
Alexandre Marti
Norbert Lange
Matthieu Zellweger
Georges Wagnieres
Den Bergh Hubert Van
Patrice Jichlinski
Pavel Kucera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9805425A priority Critical patent/FR2777782B1/fr
Application filed by Individual filed Critical Individual
Priority to DE69904033T priority patent/DE69904033T2/de
Priority to AT99913060T priority patent/ATE228018T1/de
Priority to ES99913060T priority patent/ES2188146T3/es
Priority to EP99913060A priority patent/EP1073472B1/fr
Priority to PCT/CH1999/000163 priority patent/WO1999053962A1/fr
Priority to CA002327393A priority patent/CA2327393C/fr
Priority to JP2000544365A priority patent/JP4630395B2/ja
Priority to US09/673,871 priority patent/US7348361B2/en
Publication of FR2777782A1 publication Critical patent/FR2777782A1/fr
Application granted granted Critical
Publication of FR2777782B1 publication Critical patent/FR2777782B1/fr
Priority to JP2010051284A priority patent/JP2010163445A/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
FR9805425A 1998-04-22 1998-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires Expired - Fee Related FR2777782B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9805425A FR2777782B1 (fr) 1998-04-22 1998-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
US09/673,871 US7348361B2 (en) 1998-04-22 1999-04-22 Solution for diagnosing or treating tissue pathologies
ES99913060T ES2188146T3 (es) 1998-04-22 1999-04-22 Disolucion de un ester del ala para el diagnostico o el tratamiento de lesiones tisulares.
EP99913060A EP1073472B1 (fr) 1998-04-22 1999-04-22 Solution d'un ester de l' ala pour le diagnostic ou le traitement de lesions tissulaires
PCT/CH1999/000163 WO1999053962A1 (fr) 1998-04-22 1999-04-22 Solution pour le diagnostic ou le traitement de lesions tissulaires
CA002327393A CA2327393C (fr) 1998-04-22 1999-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
DE69904033T DE69904033T2 (de) 1998-04-22 1999-04-22 E-ala enthaltende lösung für die diagnose oder therapie von gewebeschäden
AT99913060T ATE228018T1 (de) 1998-04-22 1999-04-22 E-ala enthaltende lösung für die diagnose oder therapie von gewebeschäden
JP2000544365A JP4630395B2 (ja) 1998-04-22 1999-04-22 組織病変部の診断または治療のための溶液
JP2010051284A JP2010163445A (ja) 1998-04-22 2010-03-09 組織病変部の診断または治療のための溶液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9805425A FR2777782B1 (fr) 1998-04-22 1998-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires

Publications (2)

Publication Number Publication Date
FR2777782A1 FR2777782A1 (fr) 1999-10-29
FR2777782B1 true FR2777782B1 (fr) 2001-05-18

Family

ID=9525850

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9805425A Expired - Fee Related FR2777782B1 (fr) 1998-04-22 1998-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires

Country Status (9)

Country Link
US (1) US7348361B2 (enExample)
EP (1) EP1073472B1 (enExample)
JP (2) JP4630395B2 (enExample)
AT (1) ATE228018T1 (enExample)
CA (1) CA2327393C (enExample)
DE (1) DE69904033T2 (enExample)
ES (1) ES2188146T3 (enExample)
FR (1) FR2777782B1 (enExample)
WO (1) WO1999053962A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2218570C2 (ru) * 2001-11-01 2003-12-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ флюоресцентной диагностики новообразований

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US6570001B1 (en) * 1997-06-20 2003-05-27 Institut Pasteur Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
EP1312353A1 (en) * 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20090227997A1 (en) * 2006-01-19 2009-09-10 The Regents Of The University Of Michigan System and method for photoacoustic imaging and monitoring of laser therapy
US20080123083A1 (en) * 2006-11-29 2008-05-29 The Regents Of The University Of Michigan System and Method for Photoacoustic Guided Diffuse Optical Imaging
JP5472819B2 (ja) * 2008-04-22 2014-04-16 Ｓｂｉファーマ株式会社 膀胱がん検出方法
CN102046817A (zh) * 2008-05-30 2011-05-04 杰富意钢铁株式会社 生铁制造方法
CN106692122A (zh) 2008-10-27 2017-05-24 思佰益药业股份有限公司 以5‑氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
JP2011001307A (ja) * 2009-06-19 2011-01-06 Sbi Alapromo Co Ltd ５−アミノレブリン酸による子宮頸がん判定・治療システム
WO2011107478A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
KR101723834B1 (ko) 2010-05-19 2017-04-06 에스비아이 파마 가부시키가이샤 ５-아미노레불린산 또는 그 유도체를 유효성분으로 하는 항말라리아약
WO2011161220A1 (en) * 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
US9345904B2 (en) 2011-07-01 2016-05-24 Sbi Pharmaceuticals Co., Ltd. Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid
EP2745838B1 (en) 2011-08-12 2017-07-26 SBI Pharmaceuticals Co., Ltd. Prophylactic agent and/or therapeutic agent for sepsis
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
CN106460447B (zh) * 2014-06-11 2018-12-11 日本板硝子株式会社 多层玻璃单元以及多层玻璃单元用玻璃板
US9733187B2 (en) 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
AU2017277626A1 (en) * 2016-06-08 2019-01-24 Cf Genome, Llc A chemical composition to stabilize extracellular vesicles in a blood sample and method of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
NZ303251A (en) * 1995-03-10 2000-10-27 Photocure Asa Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2218570C2 (ru) * 2001-11-01 2003-12-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ флюоресцентной диагностики новообразований

Also Published As

Publication number Publication date
EP1073472B1 (fr) 2002-11-20
ES2188146T3 (es) 2003-06-16
ATE228018T1 (de) 2002-12-15
EP1073472A1 (fr) 2001-02-07
DE69904033T2 (de) 2003-10-09
CA2327393C (fr) 2006-04-04
FR2777782A1 (fr) 1999-10-29
WO1999053962A1 (fr) 1999-10-28
DE69904033D1 (de) 2003-01-02
US7348361B2 (en) 2008-03-25
JP4630395B2 (ja) 2011-02-09
US20030158258A1 (en) 2003-08-21
JP2002512205A (ja) 2002-04-23
JP2010163445A (ja) 2010-07-29
CA2327393A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
ATE228018T1 (de) E-ala enthaltende lösung für die diagnose oder therapie von gewebeschäden
Travis The sequence of histological changes in mouse lungs after single doses of x-rays
Vellabriffa et al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa
Benson Jr et al. Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative
Omi et al. 420 nm intense continuous light therapy for acne
Ross et al. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5‐aminolaevulinic acid: implications for photodynamic treatment
JP3411195B2 (ja) 活性酸素除去剤
Wallis et al. The adult Fanconi syndrome: II. Review of eighteen cases
EP0904075A1 (en) Method for treating viral infections
US6350772B1 (en) Treatment of auto-immune diseases by photochemotherapy
Pignol et al. Selective delivery of 10B to soft tissue sarcoma using 10B-L-borophenylalanine for boron neutron capture therapy.
Preston et al. Effective short term treatment of Paget's disease with oral etidronate.
Markovic et al. Acid and alkaline phosphatase activity in bone-cyst fluid
Watanabe et al. ‘Flagellate’erythema in dermatomyositis
Sharma et al. Focal segmental glomerulosclerosis in a patient with polycythemia rubra vera
Peterson et al. A hypothesis for the molecular mechanism of tumor killing by porphyrins and light
Rothman In Vitro Studies on Pigmentation: I. The Oxidation of Tyrosine by Ultraviolet Irradiation
CA2263125A1 (en) Method for detecting cancer on skin of humans and mammals and arrangement for performing the method
Krugelis-Macrae The occurrence of porphyrin in the planarian
Lubart et al. Reactive oxygen species and photobiostimulation
Bjellerup et al. Studies on photohemolysis with special reference to demethylchlortetracycline
Miro et al. Skeletal muscle mitochondrial function in polymyalgia rheumatica and in giant cell arteritis.
AU1721797A (en) Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof
RU2041952C1 (ru) Способ обнаружения анаэробных бактерий в биологическом субстрате
RU96120962A (ru) Способ диагностики реакции опухоли при лечении онкологических больных

Legal Events

Date Code Title Description
ST Notification of lapse